
    
      This study will assess the efficacy, tolerability, and safety of escitalopram in the
      treatment of Major Depressive Disorder in patients with Alzheimer's disease over a 24-week
      period. It will also assess the efficacy and tolerability of escitalopram after 12 weeks of
      treatment.
    
  